Business PR Newswire Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG rvrisingnetwork October 27, 2025 0 Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately... Read More Read more about Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
